Core Laboratories Inc. (CLB) NEW YORK STOCK EXCHANGE INC.
$17.07 0.54 (3.27%)
Market Cap: $774.67M
As of 04/25/24 04:00 PM EDT. Market closed.
Core Laboratories Inc. (CLB)
NEW YORK STOCK EXCHANGE INC.
$17.07
0.54 (3.27%)
Market Cap: $774.67M
As of 04/25/24 04:00 PM EDT. Market closed.
Add to Portfolio
core laboratories is a leading provider of proprietary and patented reservoir description and production enhancement services. core laboratories remains dedicated to providing the technology you need to enhance your production. we continue to develop and acquire technologies that complement our existing products and services, and we disseminate these technologies throughout our global network. ... read more
COMPANY PROFILE
Sector
Manufacturing
Industry
Oil and Gas Field Machinery and Equipment Manufacturing
CEO
Lawrence V. Bruno
Full Time Employees
1,527
Sector
Manufacturing
Industry
Oil and Gas Field Machinery and Equipment Manufacturing
CEO
Lawrence V. Bruno
Full Time Employees
1,527
URL
Address
Strawinskylaan 913, Noord Holland, Amsterdam, 1077 XX.
PRICE CHART FOR CORE LABORATORIES INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$17.17
Previous Close
$16.53
Days Range
$16.52 - $16.96
52 week range
$13.82 - $27.90
Volume
693,893
Avg. Volume (30 days)
369,378
Market Cap
$774.67M
Dividend Yield
0.24%
P/E
32.67
Shares Outstanding
46,864,366
Open
$17.17
Previous Close
$16.53
Days Range
$16.52 - $16.96
52 week range
$13.82 - $27.90
Volume
693,893
Avg. Volume (30 days)
369,378
Market Cap
$774.67M
Dividend Yield
0.24%
P/E
32.67
Shares Outstanding
46,864,366
FINANCIAL STATEMENTS FOR CORE LABORATORIES INC
LOADING...
INSIDER TRANSACTIONS FOR CORE LABORATORIES INC
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Straughen Michael | Director | Apr 01, 2024 | Option Exercise | $17.13 | 3,017 | 51,681 | 19,869 | Apr 02, 2024, 05:10 PM |
Tattoli Mark Damian | SVP, Gen Counsel & Secretary | Dec 31, 2023 | Option Exercise | $17.66 | 2,716 | 47,965 | 10,377 | Jan 08, 2024, 02:50 PM |
Daniels Kevin | CAO & Treasurer | Dec 31, 2023 | Option Exercise | $17.66 | 2,834 | 50,048 | 13,115 | Jan 08, 2024, 02:50 PM |
Hill Christopher Scott | SVP & CFO | Dec 31, 2023 | Option Exercise | $17.66 | 14,195 | 250,684 | 72,049 | Jan 08, 2024, 02:49 PM |
Gresham Gwendolyn | SVP | Dec 31, 2022 | Option Exercise | $20.27 | 4,722 | 95,715 | 15,061 | Jan 08, 2024, 02:47 PM |
Gresham Gwendolyn | SVP | Dec 31, 2023 | Option Exercise | $17.66 | 5,775 | 101,986 | 23,960 | Jan 08, 2024, 02:47 PM |
Bruno Lawrence | Chairman and CEO | Dec 31, 2023 | Option Exercise | $17.66 | 39,373 | 695,327 | 163,203 | Jan 08, 2024, 02:41 PM |
Tattoli Mark Damian | SVP, Gen Counsel & Secretary | Dec 31, 2023 | Option Exercise | $17.66 | 2,654 | 46,870 | 10,439 | Jan 03, 2024, 05:50 PM |
Daniels Kevin | CAO & Treasurer | Dec 31, 2023 | Option Exercise | $17.66 | 2,769 | 48,901 | 13,180 | Jan 03, 2024, 05:47 PM |
Gresham Gwendolyn | SVP | Dec 31, 2023 | Option Exercise | $17.66 | 5,643 | 99,655 | 24,092 | Jan 03, 2024, 05:46 PM |
Hill Christopher Scott | SVP & CFO | Dec 31, 2023 | Option Exercise | $17.66 | 13,870 | 244,944 | 72,374 | Jan 03, 2024, 05:43 PM |
Bruno Lawrence | Chairman and CEO | Dec 31, 2023 | Option Exercise | $17.66 | 38,473 | 679,433 | 164,103 | Jan 03, 2024, 05:40 PM |
Tattoli Mark Damian | SVP, Gen Counsel & Secretary | Dec 01, 2023 | Option Exercise | $18.07 | 62 | 1,120 | 6,193 | Dec 04, 2023, 04:54 PM |
Daniels Kevin | CAO & Treasurer | Dec 01, 2023 | Option Exercise | $18.07 | 54 | 976 | 8,749 | Dec 04, 2023, 04:51 PM |
Tattoli Mark Damian | SVP, Gen Counsel & Secretary | Oct 01, 2023 | Option Exercise | $24.01 | 270 | 6,483 | 6,095 | Oct 03, 2023, 12:30 PM |
Tattoli Mark Damian | SVP, Gen Counsel & Secretary | Aug 01, 2023 | Option Exercise | $27.43 | 147 | 4,032 | 5,665 | Aug 02, 2023, 11:27 AM |
Tattoli Mark Damian | SVP, Gen Counsel & Secretary | May 01, 2023 | Option Exercise | $22.03 | 174 | 3,833 | 5,442 | May 02, 2023, 08:31 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Owner | Relationship | Date | Value($) |
Straughen Michael | Director | 04/01/2024 | 51,681 |
Tattoli Mark Damian | SVP, Gen Counsel & Secretary | 12/31/2023 | 47,965 |
Daniels Kevin | CAO & Treasurer | 12/31/2023 | 50,048 |
Hill Christopher Scott | SVP & CFO | 12/31/2023 | 250,684 |
Gresham Gwendolyn | SVP | 12/31/2022 | 95,715 |
Gresham Gwendolyn | SVP | 12/31/2023 | 101,986 |
Bruno Lawrence | Chairman and CEO | 12/31/2023 | 695,327 |
Tattoli Mark Damian | SVP, Gen Counsel & Secretary | 12/31/2023 | 46,870 |
Daniels Kevin | CAO & Treasurer | 12/31/2023 | 48,901 |
Gresham Gwendolyn | SVP | 12/31/2023 | 99,655 |
Hill Christopher Scott | SVP & CFO | 12/31/2023 | 244,944 |
Bruno Lawrence | Chairman and CEO | 12/31/2023 | 679,433 |
Tattoli Mark Damian | SVP, Gen Counsel & Secretary | 12/01/2023 | 1,120 |
Daniels Kevin | CAO & Treasurer | 12/01/2023 | 976 |
Tattoli Mark Damian | SVP, Gen Counsel & Secretary | 10/01/2023 | 6,483 |
Tattoli Mark Damian | SVP, Gen Counsel & Secretary | 08/01/2023 | 4,032 |
Tattoli Mark Damian | SVP, Gen Counsel & Secretary | 05/01/2023 | 3,833 |
Load More Insider Transactions
FUNDS WITH A POSITION IN CORE LABORATORIES INC
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
ARIEL INVESTMENTS, LLC | 8,988,399 | 1.58% | -0.83% | Value |
BLACKROCK INC. | 7,979,470 | 0.00359% | 2.85% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 1,000,731 | 0.00185% | 6.24% | Other |
ROYCE & ASSOCIATES LP | 914,274 | 0.15% | 32.64% | Value |
FISHER ASSET MANAGEMENT, LLC | 754,407 | 0.00704% | 21.64% | Other |
D. E. SHAW & CO., INC. | 227,442 | 0.00351% | 12.97% | Other |
BALYASNY ASSET MANAGEMENT L.P. | 12,340 | 0.00041% | -35.08% | Event Driven |
PLATINUM INVESTMENT MANAGEMENT LTD | 5,577 | 0.004% | 43.77% | Growth At A Reasonable Price, Value |
BARROW HANLEY MEWHINNEY & STRAUSS LLC | 176 | 0.00001% | 104.65% | Value |
CHANGE IN SHARES OUTSTANDING FOR CORE LABORATORIES INC
STOCK BUYBACKS FOR CORE LABORATORIES INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
-0.17%
1Q
06/30/2023
0.05%
2Q
03/31/2023
0.09%
3Q
12/31/2022
1.52%
4Q
09/30/2022
1.09%
5Q
06/30/2022
0.81%
6Q
03/31/2022
2.65%
7Q
12/31/2021
2.73%
8Q
09/30/2021
0.84%
9Q
06/30/2021
0.89%
10Q
03/31/2021
3.39%
11Q
12/31/2020
6.80%
12Q
09/30/2020
6.81%
13Q
06/30/2020
6.86%
14Q
03/31/2020
6.92%
15Q
12/31/2019
6.44%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR CORE LABORATORIES INC
LOADING...